Greater Glasgow and Clyde Medicines

This blog updates prescribers on changes to the preferred brand of oxycodone modified-release tablets.

The NHSGGC Adult Gentamicin: Prescribing, Administration & Monitoring (PAM) chart has been updated. Key changes: The NHSGGC ‘Intravenous Gentamicin Patient Information’ leaflet is now...

Key messages: The Pharmacy Person Centred Care Group published a Patient Information Leaflet (PIL) 

WARNING – Antibiotic treatment failure risk Raising awareness of the interaction between tetracyclines and fluoroquinolone antibiotics with multivalent cation-containing products (e.g. ir...

This post summarises the latest NHS Greater Glasgow and Clyde decisions relating to new medicines considered by the Area Drug and Therapeutics Committee (ADTC) and uses a nationally developed format specifically aimed for patients and the public.

For full details of the medicines included in this post that are available for use, including any restrictions on prescribing, please see the relevant entry in the GGC Formulary

This post summarise the guidelines that have changed in the most recent content update to the Adult Therapeutics Handbook

New Adult NHSGGC Guidelines now available on StaffNet

Semglee®  – preferred brand of  INSULIN GLARGINE The patent for insulin glargine 100 units/ml (Lantus®) has expired. Biosim...

https://www.choiceandmedication.org/nhs24/   Choice and medication is a free resource hosted within NHS Inform for use in NHS Scotland that provides u...

Direct-acting oral anticoagulants (DOACs): increased risk of recurrent thrombotic events in patients with antiphospholipid syndrome  Following an EU review, the Summary of Product Characteristics (...